Spotted on
Novadip Biosciences
Novadip Biosciences develops regenerative medicine therapies built from a patient's own tissue, with its lead candidates now in late stage clinical trials. The Mont Saint Guibert based company closed a 10.4 million euro convertible financing round in September 2026, taking total funding past 137 million euro since inception.
TECHnicalBeep
Sponsored by:
technicalbeep.com/maps/startups/novadip-biosciences
European ecosystem maps